Added to YB: 2023-09-21
Pitch date: 2023-09-21
INZY [bullish]
Inozyme Pharma, Inc.
-13.61%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Inozyme Pharma, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for rare diseases that affect bone health and blood vessel function.
Market Cap
$259.7M
Pitch Price
$4.63
Price Target
N/A
Dividend
N/A
EV/EBITDA
-2.13
P/E
-2.38
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
INOZYME PHARMA INC INZY
A summary for this pitch has not been created yet.
Read full article (0 min)